ViaDerma (ViaDerma) FCF Yield % : 0.00 (As of Jun. 22, 2024)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, ViaDerma's Trailing 12-Month Free Cash Flow is $-2.46 Mil, and Market Cap is $6.79 Mil. Therefore, ViaDerma's FCF Yield % for today is 0.00%.

The historical rank and industry rank for ViaDerma's FCF Yield % or its related term are showing as below:

VDRM's FCF Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.16
* Ranked among companies with meaningful FCF Yield % only.

ViaDerma's FCF Margin % for the quarter that ended in Jun. 2012 was 0.64%.

ViaDerma FCF Yield % Historical Data

The historical data trend for ViaDerma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma FCF Yield % Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

FCF Yield %

-26.32

-268.72

430.98

-12,299.74

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
FCF Yield %	Get a 7-Day Free Trial															-97.95	-2,457.03	16,006.41	853.48	14.37

Competitive Comparison of ViaDerma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where ViaDerma's FCF Yield % falls into.

ViaDerma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

ViaDerma's FCF Yield % for the fiscal year that ended in Dec. 2011 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.378	/	0.027464
	=	-12,299.74%

ViaDerma's annualized FCF Yield % for the quarter that ended in Jun. 2012 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.037	*	4	/	1.0299
	=	14.37%

ViaDerma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

ViaDerma FCF Yield % Related Terms

Thank you for viewing the detailed overview of ViaDerma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.